Here's the nasty reason why you should never trust the plastic hygiene liners on bathing suits
Although bathing suit bottoms usually have a plastic hygiene liner in them — according to a microbiologist, that's the last thing you want near your privates.
Nicholas Aicher is a scientist from Chicago. He took it upon himself to swab the plastic seal of two different bathing suit bottoms that hung in a retail store and place them into a petri dish to see what kind of bacteria live on them.
'I thought it would be fun for people to know all the little nastiness that we don't think about every day,' he told What's The Jam.
Once home, he transferred the samples to an incubator and let them sit for a bit before revealing some shocking, gross news.
The sample from one of the bathing suits had a high amount of Staphylococcus bacteria, which causes staph infections.
Common symptoms of staph infections include boils and oozing blisters, and they can turn fatal if the 'bacteria invade deeper into your body, entering your bloodstream, joints, bones, lungs or heart,' according to Mayo Clinic.
The results from the other sampled swimsuit were less severe, although it did have 'smaller pin-prick colonies' of the bacteria, according to Jam Press.
The moral of the story is to always try on bathing suits with some sort of barrier — whether it be full coverage underwear or tight-fitting pants, like leggings — between your skin and the fabric.
And bathing suits are not the only things to be wary of.
A TikToker (@onenevertwhoo_one), who only wanted to be referred to by his social media handle, contracted a skin infection most likely due to never washing the clothes he bought from a thrift store, according to Jam Press.
He explained in a video — that has since gone viral — that he contracted molluscum contagiosum, a viral skin infection that consists of small, raised, painless bumps on the skin.
Apparently the contagious condition that spreads through either skin-to-skin contact or contact with infected objects is harmless and does not require treatment, according to NeedToKnow.
Dr. Charles Puza, a board-certified NYC dermatologist, also reiterated in a TikTok video the importance of washing your clothes before putting them on, '…especially if you like fast fashion like Shein and Temu.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
14 minutes ago
- Yahoo
Paleontologists Discover Prehistoric ‘Dance Floor' Where Dinosaurs Courted Mates
Dinosaurs may have ruled the prehistoric world with their size and strength, but apparently, they also had moves. A team of researchers in Colorado has uncovered one of the largest known dinosaur 'dance arenas,' an ancient mating ground where male theropods likely performed ritualistic displays to attract females. Using high-resolution drone photography and 3D modeling at Dinosaur Ridge near Denver, the team identified dozens of clustered scrape marks in the sandstone — a prehistoric 'dance floor' etched into the earth more than 100 million years ago. The site builds on previous discoveries of similar scrape marks called leks, where male animals gather to compete for female attention. But this newly analyzed area suggests a massive congregation, with markings that scientists believe show not just nest displays but physical courtship performances. 'These trace fossils, we interpret them to be evidence of dinosaur courtship activities,' study co-author Caldwell Buntin of Old Dominion University told ABC News. 'They likely built display nests and performed some kind of dance or scraping activity to impress mates, which are behaviors we still see in modern birds like plovers.' The scrape marks belong to theropod dinosaurs, a group that includes raptors and the infamous T. rex. Based on the impressions, these dinosaurs stood around three to four feet at the hip and stretched up to 16 feet long. The patterns vary from shallow toe marks to deep bowl-shaped scrapes—even circular patterns hinting at dance-like movements. The discovery, published in the latest research from Dinosaur Ridge, pushes our understanding of dinosaur behavior beyond hunting and migration. It also suggests that some mating rituals date back tens of millions of years and could be part of a deep evolutionary connection between dinosaurs and modern birds. Perhaps best of all, the site is open to the public, meaning visitors can stand right where these ancient creatures showed off their best moves. 'It's rare to find evidence of behavior, not just bones or tracks,' said co-author Neffra Matthews. 'And it's even rarer to find a site like this that people can actually go see for themselves.' Turns out, dinosaurs weren't just prehistoric predators. They may have been prehistoric showmen, Discover Prehistoric 'Dance Floor' Where Dinosaurs Courted Mates first appeared on Men's Journal on Jul 21, 2025 Solve the daily Crossword
Yahoo
an hour ago
- Yahoo
Genentech Provides Update on Astegolimab in Chronic Obstructive Pulmonary Disease
– The pivotal Phase IIb ALIENTO study met the primary endpoint of a statistically significant reduction in the annualized exacerbation rate (AER) at 52 weeks when astegolimab was given every two weeks – – The Phase III ARNASA study did not meet the primary endpoint of a statistically significant reduction in the AER at 52 weeks – – The safety profile of astegolimab was consistent with previously reported data, with no new safety signals identified – – Analysis of the ALIENTO and ARNASA data will be discussed with regulatory authorities and shared at an upcoming medical meeting – SOUTH SAN FRANCISCO, Calif., July 21, 2025--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today topline results from the pivotal Phase IIb ALIENTO (n=1,301) and the Phase III ARNASA (n=1,375) trials investigating astegolimab compared to placebo, on top of standard of care maintenance therapy in people with moderate to very severe chronic obstructive pulmonary disease (COPD). The studies included a broad population: both former and current smokers, regardless of blood eosinophil count, who have a history of frequent exacerbations. The pivotal Phase IIb ALIENTO study met its primary endpoint and showed that astegolimab reduced the annualized exacerbation rate (AER) by a statistically significant 15.4% at 52 weeks, when given every two weeks. However, the Phase III ARNASA study did not meet its primary endpoint of a statistically significant reduction in the AER, demonstrating a numerical 14.5% reduction at 52 weeks when astegolimab was given every two weeks. The results were generally consistent across secondary endpoints in both studies. The total number of exacerbations was lower than prospectively anticipated in both trials. The safety profile of astegolimab was consistent with previously reported data, with no new safety signals identified. "While COPD remains the third leading cause of death worldwide, patients and families have limited treatment options for managing this debilitating and complex disease," said Levi Garraway, M.D., Ph.D., chief medical officer and head of Global Product Development. "This was the first set of studies in an 'all-comers' COPD population, and we will discuss these data with regulatory authorities to evaluate next steps for astegolimab." Detailed results from ALIENTO and ARNASA will be shared at an upcoming medical meeting. About the ALIENTO and ARNASA studies Astegolimab is an investigational, fully human anti-ST2 monoclonal antibody designed to bind with high affinity to the ST2 receptor, thereby blocking the signaling of IL-33. The astegolimab COPD pivotal program consists of two registrational studies, the Phase IIb ALIENTO (NCT05037929) and Phase III ARNASA (NCT05595642) studies. Both ALIENTO and ARNASA are double-blinded, placebo-controlled, multi-center studies that evaluate the efficacy and safety of astegolimab administered every two or every four weeks in patients with COPD on top of standard of care maintenance therapy. Patients in the studies included former and current smokers, regardless of blood eosinophil count, who have a history of frequent exacerbations. The primary analysis is based on the initial phase of the study, which consisted of 1,301 patients for ALIENTO and 1,375 patients for ARNASA. The primary endpoint is the reduction in the annualized rate of moderate and severe COPD exacerbations (AER) over the 52-week treatment period. AER is the total number of exacerbations (a sudden worsening in airway function and respiratory symptoms) occurring over the relevant treatment period, divided by the total number of patient years. Standard of care maintenance therapy for both studies was one of the following combinations - inhaled corticosteroid (ICS) plus long-acting beta-agonist (LABA); long-acting muscarinic antagonist (LAMA) plus LABA; ICS plus LAMA plus LABA. About Genentech Founded more than 40 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious and life-threatening medical conditions. The company, a member of the Roche Group, has headquarters in South San Francisco, California. For additional information about the company, please visit View source version on Contacts Media Contact:Lindsey Mathias, (650) 467-6800 Advocacy Contact:Del Conyers, (571) 684-1616 Investor Contacts:Loren Kalm, (650) 225-3217Bruno Eschli, +41 61 68-75284 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
"I thought I might be dead in a few months" - Kareem Abdul-Jabbar on getting diagnosed with leukemia
"I thought I might be dead in a few months" - Kareem Abdul-Jabbar on getting diagnosed with leukemia originally appeared on Basketball Network. Kareem Abdul-Jabbar, born in 1947, is nearing 80. Despite that advanced age, he still seems to be going strong. Basketball fans should appreciate that, not just for his longevity, but because one story about the sports icon shows how quickly it can all end. In 2011, the Hall of Famer shared his reaction to a leukemia diagnosis — news that hit like a thunderbolt. Fearing the worst In November 2009, Abdul-Jabbar revealed he was diagnosed with Philadelphia chromosome-positive chronic myeloid leukemia, a blood and bone marrow cancer. The two-time Finals MVP said he had received the devastating news in December 2008. While shocking on its own, it hit harder because of memories of his close friend Bruno Kirby. The actor, known for "When Harry Met Sally…" and "Good Morning, Vietnam," died from leukemia complications in August 2006, "within 30 days" of his diagnosis, Kareem recalled. Of course, every case is different, and disease progression varies. Still, the Los Angeles Lakers legend admitted he instantly feared the worst when he received the same diagnosis, mainly because he "really had no understanding" of what he was dealing with. "I thought I might be dead in a few months," said Abul-Jabbar, per battle Fast forward to 2011, Kareem took to X (formerly Twitter) with hopeful news: he was cancer-free — a statement he later corrected. "You're never really cancer-free and I should have known that," he said. "My cancer right now is at an absolute minimum… It's not life-threatening at this point in my life." Following a similar approach to former superstar teammate Magic Johnson's powerful handling of his HIV diagnosis, Abdul-Jabbar faced his own illness head-on. For instance, the New York native became a spokesperson for Novartis, makers of Gleevec, the drug that transforms chronic myeloid leukemia into a manageable condition and boosts survival rates. "Medical science has made great strides over the last 20 years," Kareem noted. "People in my position are able to live their lives to the fullest. I'm very grateful for that. I'm lucky that they caught it in enough time, and I've responded well to the medication. If not for the success that medicine has made, I might be part of a much different story right now." It wasn't the only time cancer challenged him. In 2020, Abdul-Jabbar revealed he'd been diagnosed with prostate cancer eleven years earlier. And while he fought it again, the now 78-year-old didn't forget those in the same fight. Kareem acknowledged that as an NBA star, he had access to top-tier medical care — something many in the Black community lack. "While I'm grateful for my advantages, I'm acutely aware that many others in the Black community do not have the same options and that is my responsibility to join with those fighting to change that," he wrote, per Good Morning America. "Because Black lives are at risk. Serious risk." Abdul-Jabbar was always the vocal leader in the Showtime Lakers locker room — a voice he clearly hasn't lost, even with adversity testing him time and story was originally reported by Basketball Network on Jul 20, 2025, where it first appeared.
